| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
13,390,000 |
| Market
Cap: |
67.22(M) |
| Last
Volume: |
18,970 |
Avg
Vol: |
18,917 |
| 52
Week Range: |
$4.27 - $7.32 |
|
| Level
I Sector: |
Consumer Discretionary |
| Level
II Sector: |
Leisure |
| Level
III Sector: |
Restaurants |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 9.4 |
| Insider 3/6 Months : 10 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Champions Oncology is engaged in drug discovery and development through research strategies and pharmacology, biomarker and data platforms. Co.'s research services utilize its research center to assist pharmaceutical and biotechnology companies with their drug development process. Co.'s Software as a service business is centered around its proprietary software platform and data tool, Lumin Bioinformatics, which contains information derived from its research services and clinical studies. Co.'s drug discovery and development business utilizes the computational and experimental capabilities within its platforms.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
25,044 |
75,504 |
87,886 |
| Total Buy Value |
$0 |
$142,144 |
$441,769 |
$491,738 |
| Total People Bought |
0 |
1 |
1 |
2 |
| Total Buy Transactions |
0 |
11 |
25 |
26 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mendelson Daniel Newman |
Director |
– • – |
2024-01-12 |
4 |
B |
$6.50 |
$6,500 |
D/D |
1,000 |
198,625 |
2.39 |
-25% |
|
| Mendelson Daniel Newman |
Director |
– • – |
2024-01-11 |
4 |
B |
$6.27 |
$12,540 |
D/D |
2,000 |
197,625 |
2.39 |
-19% |
|
| Mendelson Daniel Newman |
Director |
– • – |
2024-01-10 |
4 |
B |
$6.31 |
$18,577 |
D/D |
2,944 |
195,625 |
2.39 |
-18% |
|
| Mendelson Daniel Newman |
Director |
– • – |
2024-01-09 |
4 |
B |
$6.25 |
$18,750 |
D/D |
3,000 |
192,681 |
2.39 |
-19% |
|
| Mendelson Daniel Newman |
Director |
– • – |
2024-01-08 |
4 |
B |
$6.15 |
$6,150 |
D/D |
1,000 |
189,681 |
2.39 |
-18% |
|
| Mendelson Daniel Newman |
Director |
– • – |
2024-01-05 |
4 |
B |
$6.09 |
$12,180 |
D/D |
2,000 |
188,681 |
2.39 |
-17% |
|
| Mendelson Daniel Newman |
Director |
– • – |
2024-01-04 |
4 |
B |
$6.12 |
$18,360 |
D/D |
3,000 |
186,681 |
2.39 |
-17% |
|
| Mendelson Daniel Newman |
Director |
– • – |
2024-01-03 |
4 |
B |
$5.83 |
$2,915 |
D/D |
500 |
183,681 |
2.31 |
-18% |
|
| Mendelson Daniel Newman |
Director |
– • – |
2023-12-21 |
4 |
B |
$4.92 |
$12,300 |
D/D |
2,500 |
183,181 |
2.39 |
3% |
|
| Mendelson Daniel Newman |
Director |
– • – |
2023-12-20 |
4 |
B |
$4.82 |
$10,122 |
D/D |
2,100 |
180,681 |
2.39 |
2% |
|
| Mendelson Daniel Newman |
Director |
– • – |
2023-12-19 |
4 |
B |
$4.75 |
$23,750 |
D/D |
5,000 |
178,581 |
2.39 |
11% |
|
| Ackerman Joel |
Director |
– • – |
2023-10-17 |
4 |
OE |
$2.10 |
$240,559 |
D/D |
114,552 |
856,997 |
|
- |
|
| Mendelson Daniel Newman |
Director |
– • – |
2023-10-11 |
4 |
B |
$6.40 |
$32,000 |
D/D |
5,000 |
163,081 |
2.39 |
-8% |
|
| Mendelson Daniel Newman |
Director |
– • – |
2023-10-10 |
4 |
B |
$6.41 |
$7,051 |
D/D |
1,100 |
158,081 |
2.39 |
-7% |
|
| Mendelson Daniel Newman |
Director |
– • – |
2023-10-06 |
4 |
B |
$6.48 |
$9,914 |
D/D |
1,530 |
156,981 |
2.39 |
-12% |
|
| Mendelson Daniel Newman |
Director |
– • – |
2023-10-05 |
4 |
B |
$6.47 |
$12,940 |
D/D |
2,000 |
155,451 |
2.39 |
-3% |
|
| Mendelson Daniel Newman |
Director |
– • – |
2023-10-04 |
4 |
B |
$6.40 |
$32,000 |
D/D |
5,000 |
153,451 |
2.39 |
-5% |
|
| Mendelson Daniel Newman |
Director |
– • – |
2023-10-03 |
4 |
B |
$6.30 |
$15,750 |
D/D |
2,500 |
148,451 |
2.39 |
-4% |
|
| Mendelson Daniel Newman |
Director |
– • – |
2023-09-29 |
4 |
B |
$6.16 |
$24,640 |
D/D |
4,000 |
173,581 |
2.39 |
-3% |
|
| Mendelson Daniel Newman |
Director |
– • – |
2023-09-28 |
4 |
B |
$6.22 |
$31,100 |
D/D |
5,000 |
169,581 |
2.39 |
-0% |
|
| Mendelson Daniel Newman |
Director |
– • – |
2023-09-27 |
4 |
B |
$5.95 |
$8,925 |
D/D |
1,500 |
164,581 |
2.39 |
8% |
|
| Mendelson Daniel Newman |
Director |
– • – |
2023-09-26 |
4 |
B |
$5.65 |
$28,250 |
D/D |
5,000 |
145,951 |
2.39 |
7% |
|
| Mendelson Daniel Newman |
Director |
– • – |
2023-09-22 |
4 |
B |
$5.50 |
$20,966 |
D/D |
3,812 |
140,951 |
2.39 |
7% |
|
| Mendelson Daniel Newman |
Director |
– • – |
2023-09-21 |
4 |
B |
$5.51 |
$27,550 |
D/D |
5,000 |
137,139 |
2.39 |
9% |
|
| Mendelson Daniel Newman |
Director |
– • – |
2023-09-20 |
4 |
B |
$5.51 |
$22,139 |
D/D |
4,018 |
132,139 |
2.39 |
11% |
|
107 Records found
|
|
Page 1 of 5 |
|
|
0.04 (0.79%) 
